Antibiotic use and misuse in the neonatal intensive care unit

Nidhi Tripathi1, C Michael Cotten, P Brian Smith

  • 1Duke University Medical Center, Durham, NC 27710, USA.

Clinics in Perinatology
|February 21, 2012
PubMed

Insights

Neonatal sepsis, a major threat to preterm infants, requires prompt antibiotic treatment. Shorter courses of narrow-spectrum antibiotics are recommended to minimize adverse effects while effectively treating suspected infections.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Neonatal sepsis poses a significant threat to infant health, particularly in premature infants.
  • Empiric antibiotic treatment is standard practice but carries risks of adverse outcomes.
  • Common neonatal pathogens are often susceptible to narrow-spectrum antibiotics.

Purpose of the Study:

  • To evaluate the optimal antibiotic strategy for neonatal sepsis.
  • To identify factors influencing empiric antibiotic choice and duration.
  • To balance the risks of untreated sepsis against antibiotic-related adverse effects.

Main Methods:

  • Review of clinical guidelines and treatment protocols for neonatal sepsis.
  • Analysis of antibiotic susceptibility patterns for common neonatal pathogens.
  • Correlation of treatment choices with center-based risk factors.

Main Results:

  • Broad-spectrum and prolonged empiric antibiotic use are linked to negative outcomes.
  • Narrow-spectrum antibiotics are effective against most common neonatal pathogens.
  • Antibiotic selection and treatment duration are influenced by institutional factors.

Conclusions:

  • Short courses of narrow-spectrum antibiotics should be prioritized for neonatal sepsis when clinically appropriate.
  • Treatment decisions must weigh the risks of undertreatment against the harms of antibiotic exposure.
  • Optimizing empiric antibiotic therapy can improve outcomes for infants with suspected sepsis.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...